成年人急性严重喘的硫酸治疗-系统性审查和元分析
Alma Holm Rovsing1, Osman Savran1, Charlotte Suppli Ulrik2
1Department of Respiratory Medicine, Copenhagen University Hospital-Hvidovre, Hvidovre, Denmark.
Frontiers in allergy
|August 14, 2023
概括
硫酸 (MgSO4) 显示出对肺功能,特别是呼吸流量峰值 (PEF) 的有利影响,当雾化用于耐性喘恶化时. 然而,它对住院病人的影响在各个研究中仍然不那么一致.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 耐药性喘恶化是一个重大的临床挑战,往往需要先进的治疗策略.
- 补充硫酸 (MgSO4) 在治疗严重喘发作中的作用是正在进行的临床辩论的主题.
研究的目的:
- 系统地审查和分析目前关于硫酸 (MgSO4) 作为成人喘恶化的辅助疗法的有效性的证据,这些证据与标准治疗不相容.
主要方法:
- 根据PRISMA指南进行了系统审查,并在2023年4月更新了文献搜索.
- 用RStudio.com进行元分析时采用了一个随机效应模型.
- 分析中包括了17个随机对照试验.
主要成果:
- 在九项研究中的六项中,雾化硫酸 (MgSO4) 对肺功能产生了有利影响,特别是1秒内最大呼气流量 (PEF) 和强迫呼气体积 (FEV1).
- 静脉注射 (IV) 硫酸 (MgSO4) 在与安慰剂相比,在九项研究中的三项中显示出对肺功能有显著影响.
- 分析表明,与安慰剂相比,雾化MgSO4对PEF的影响更大 (MD,23.57;95% CI,-2.48至49.62,p < 0.01),而IVMgSO4没有显示出统计学上显著的差异 (MD,5.49;95%CI,-18.67至29.65,p = 0.10).
- 较少的研究报告了MgSO4对雾化和静脉注射的入院率的显著影响.
结论:
- 在大约三分之二的研究中,硫酸盐 (MgSO4) 对喘恶化的治疗对肺功能 (FEV1/PEF) 产生了积极影响.
- 对硫酸 (MgSO4) 对减少喘恶化病例入院的影响的证据不那么强大.
- 与静脉注射相比,雾化硫酸在耐火性喘中改善肺功能参数方面似乎更有效.
相关概念视频
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
302
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
302
01:24Antiasthma Drugs: Methylxanthines
269
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
269
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
346
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
346
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
299
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
299
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
340
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
340